Physician

Kevin Michael Wells, MD

According to 2025 Medicare claims, Kevin Wells, MD (NPI: 1154765733) practices ophthalmology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is RETINA CENTER P A (NPI: 1922006246; TIN: 200872732) and primary practice location at 77802-2601.

Wells' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 777 traditional Medicare patients, billed 18,552 HCPCS/CPT codes, and received $1,878,211 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 577 prescription claims across 165 beneficiaries totaling $45,804 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 5 records totaling $130. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $27,020 to $1,878,211. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $18,414 to $45,804. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2017 Medicare payment: $27,020 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $62,036 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $859,932 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,904,102 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,019,728 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,949,751 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,152,838 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,878,211 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017193292$27,020
2018416645$62,036
20198737,512$859,932
202079114,981$1,904,102
202183615,273$2,019,728
202283714,913$1,949,751
202390116,279$2,152,838
202477718,552$1,878,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$38K$77K2015 Drug cost: $18,414 (USD; Tot_Drug_Cst)2016 Drug cost: $16,637 (USD; Tot_Drug_Cst)2017 Drug cost: $11,972 (USD; Tot_Drug_Cst)2018 Drug cost: $6,962 (USD; Tot_Drug_Cst)2019 Drug cost: $12,150 (USD; Tot_Drug_Cst)2020 Drug cost: $52,828 (USD; Tot_Drug_Cst)2021 Drug cost: $44,726 (USD; Tot_Drug_Cst)2022 Drug cost: $69,567 (USD; Tot_Drug_Cst)2023 Drug cost: $76,979 (USD; Tot_Drug_Cst)2024 Drug cost: $45,804 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201561274$18,414
201651198$16,637
201770207$11,972
201864137$6,962
201993186$12,150
2020132543$52,828
2021149563$44,726
2022158607$69,567
2023191698$76,979
2024165577$45,804

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system156156$107
92014Established patient complete exam of visual system6922,654$92
67028Injection of drug into eye3532,691$88
J7999Compounded drug, not otherwise classified2401,517$66
92134Imaging of retina7402,817$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium351,408$14,425
Bromfenac SodiumBromfenac Sodium401,540$5,672
LumiganBimatoprost11928$5,530
Prednisolone AcetatePrednisolone Acetate903,806$4,783
DifluprednateDifluprednate451,029$4,253

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$130Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Michael Wells, MD?

Tedicare shows public-source Medicare data for Kevin Michael Wells, MD (NPI 1154765733), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Michael Wells, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin Michael Wells, MD?

Kevin Michael Wells, MD is linked to RETINA CENTER P A (billing NPI 1922006246) in the available physician profile data.

Does Kevin Michael Wells, MD have Open Payments data?

Kevin Michael Wells, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.